loadpatents
Patent applications and USPTO patent grants for Medina; Julio C..The latest application filed is for "piperidinone derivatives as mdm2 inhibitors for the treatment of cancer".
Patent | Date |
---|---|
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer Grant 11,407,721 - Bartberger , et al. August 9, 2 | 2022-08-09 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20220169611 - Bartberger; Michael D. ;   et al. | 2022-06-02 |
Compounds that inhibit MCL-1 protein Grant 11,306,107 - Brown , et al. April 19, 2 | 2022-04-19 |
Inhibitors of glucocorticoid receptor Grant 11,208,432 - Sun , et al. December 28, 2 | 2021-12-28 |
Inhibitors Of Glucocorticoid Receptor App 20210395295 - SUN; Daqing ;   et al. | 2021-12-23 |
Inhibitors Of Glucocorticoid Receptor App 20210379084 - SUN; Daqing ;   et al. | 2021-12-09 |
Inhibitors of glucocorticoid receptor Grant 11,124,537 - Sun , et al. September 21, 2 | 2021-09-21 |
Inhibitors of glucocorticoid receptor Grant 11,110,103 - Sun , et al. September 7, 2 | 2021-09-07 |
Compounds That Inhibit Mcl-1 Protein App 20210230189 - BROWN; Sean P. ;   et al. | 2021-07-29 |
Heteroaryl-substituted triazoles as APJ receptor agonists Grant 11,046,680 - Chen , et al. June 29, 2 | 2021-06-29 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20210179560 - Bartberger; Michael D. ;   et al. | 2021-06-17 |
Inhibitors Of Glucocorticoid Receptor App 20210023095 - SUN; Daqing ;   et al. | 2021-01-28 |
Inhibitors Of Glucocorticoid Receptor App 20210017220 - SUN; Daqing ;   et al. | 2021-01-21 |
Inhibitors Of Glucocorticoid Receptor App 20210017219 - SUN; Daqing ;   et al. | 2021-01-21 |
Inhibitors Of Glucocorticoid Receptor App 20210002324 - SUN; Daqing ;   et al. | 2021-01-07 |
Inhibitors of glucocorticoid receptor Grant 10,836,789 - Sun , et al. November 17, 2 | 2020-11-17 |
Inhibitors Of Glucocorticoid Receptor App 20200291058 - SUN; Daqing ;   et al. | 2020-09-17 |
Triazole furan compounds as agonists of the APJ receptor Grant 10,736,883 - Brown , et al. A | 2020-08-11 |
Inhibitors of glucocorticoid receptor Grant 10,723,759 - Sun , et al. | 2020-07-28 |
Inhibitors Of Glucocorticoid Receptor App 20200055892 - SUN; Daqing ;   et al. | 2020-02-20 |
Inhibitors of glucocorticoid receptor Grant 10,472,387 - Sun , et al. Nov | 2019-11-12 |
Triazole Furan Compounds As Agonists Of The Apj Receptor App 20190275008 - BROWN; Matthew ;   et al. | 2019-09-12 |
Inhibitors Of Glucocorticoid Receptor App 20190218246 - SUN; Daqing ;   et al. | 2019-07-18 |
Triazole agonists of the APJ receptor Grant 10,221,162 - Chen , et al. | 2019-03-05 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20190062276 - Bartberger; Michael D. ;   et al. | 2019-02-28 |
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20180354918 - BARTBERGER; Michael D. ;   et al. | 2018-12-13 |
Triazole Agonists Of The Apj Receptor App 20180319773 - CHEN; Ning ;   et al. | 2018-11-08 |
Triazole agonists of the APJ receptor Grant 9,868,721 - Chen , et al. January 16, 2 | 2018-01-16 |
Intermediates for preparing triazole agonists of the APJ receptor Grant 9,845,310 - Chen , et al. December 19, 2 | 2017-12-19 |
Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancer Grant 9,758,495 - Gonzalez Buenrostro , et al. September 12, 2 | 2017-09-12 |
Methods for preparing triazole agonists of the APJ receptor Grant 9,751,864 - Chen , et al. September 5, 2 | 2017-09-05 |
Triazole agonists of the APJ receptor Grant 9,745,286 - Chen , et al. August 29, 2 | 2017-08-29 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20170144971 - BARTBERGER; Michael D. ;   et al. | 2017-05-25 |
Triazole agonists of the APJ receptor Grant 9,656,997 - Chen , et al. May 23, 2 | 2017-05-23 |
Intermediates for preparing triazole agonists of the APJ receptor Grant 9,656,998 - Chen , et al. May 23, 2 | 2017-05-23 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,593,129 - Bartberger , et al. March 14, 2 | 2017-03-14 |
Triazole agonists of the APJ receptor Grant 9,573,936 - Chen , et al. February 21, 2 | 2017-02-21 |
Triazole Agonists Of The Apj Receptor App 20170042871 - Chen; Ning ;   et al. | 2017-02-16 |
Triazole Agonists Of The Apj Receptor App 20170044131 - CHEN; Ning ;   et al. | 2017-02-16 |
Triazole Agonists Of The Apj Receptor App 20170042897 - Chen; Ning ;   et al. | 2017-02-16 |
Triazole Agonists Of The Apj Receptor App 20170042872 - CHEN; Ning ;   et al. | 2017-02-16 |
Triazole Agonists Of The Apj Receptor App 20170035744 - CHEN; Ning ;   et al. | 2017-02-09 |
Triazole Agonists Of The Apj Receptor App 20170037026 - CHEN; Ning ;   et al. | 2017-02-09 |
Triazole Agonists Of The Apj Receptor App 20160340336 - Chen; Ning ;   et al. | 2016-11-24 |
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer Grant 9,376,425 - Bartberger , et al. June 28, 2 | 2016-06-28 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20160137667 - BARTBERGER; Michael D. ;   et al. | 2016-05-19 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,296,736 - Bartberger , et al. March 29, 2 | 2016-03-29 |
Heteroaryl Acid Morpholinone Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20160039774 - GONZALEZ BUENROSTRO; Ana ;   et al. | 2016-02-11 |
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20160002185 - BARTBERGER; Michael D. ;   et al. | 2016-01-07 |
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140315895 - Bartberger; Michael D. ;   et al. | 2014-10-23 |
Heterocyclic Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20140235629 - Bartberger; Michael D. ;   et al. | 2014-08-21 |
Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions Grant 8,785,468 - Du , et al. July 22, 2 | 2014-07-22 |
Spirocyclic GPR40 modulators Grant 8,748,462 - Brown , et al. June 10, 2 | 2014-06-10 |
Phenyl acetic acid derivatives Grant 8,183,293 - Grillo , et al. May 22, 2 | 2012-05-22 |
Phenylanaline Amide Derivatives Useful For Treating Insulin-related Diseases And Conditions App 20120115811 - Du; Xiaohui ;   et al. | 2012-05-10 |
Substituted biphenyl GPR40 modulators Grant 8,030,354 - Brown , et al. October 4, 2 | 2011-10-04 |
Heterocyclic GPR40 modulators Grant 8,003,648 - Beck , et al. August 23, 2 | 2011-08-23 |
Spirocyclic Gpr40 Modulators App 20110190330 - Brown; Sean P. ;   et al. | 2011-08-04 |
Compounds and methods useful for treating asthma and allergic inflammation Grant 7,960,567 - Brown , et al. June 14, 2 | 2011-06-14 |
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases Grant 7,939,538 - Fu , et al. May 10, 2 | 2011-05-10 |
Cxcr3 Antagonists App 20110034487 - Chen; Xiaoqi ;   et al. | 2011-02-10 |
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders Grant 7,816,367 - Akerman , et al. October 19, 2 | 2010-10-19 |
Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders Grant 7,799,795 - Bergeron , et al. September 21, 2 | 2010-09-21 |
Benzo-fused Compounds For Use In Treating Metabolic Disorders App 20100137323 - Brown; Sean P. ;   et al. | 2010-06-03 |
Heterocyclic GPR40 modulators Grant 7,714,008 - Beck , et al. May 11, 2 | 2010-05-11 |
Benzo-fused compounds for use in treating metabolic disorders Grant 7,687,526 - Brown , et al. March 30, 2 | 2010-03-30 |
Heterocyclic Gpr40 Modulators App 20100075974 - Beck; Hilary ;   et al. | 2010-03-25 |
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders Grant 7,649,110 - Akerman , et al. January 19, 2 | 2010-01-19 |
Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders App 20090275598 - Akerman; Michelle ;   et al. | 2009-11-05 |
Phenyl acetic acid derivatives as inflammation modulators App 20090275659 - Grillo; Mark ;   et al. | 2009-11-05 |
Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders Grant 7,582,803 - Akerman , et al. September 1, 2 | 2009-09-01 |
Asthma and allergic inflammation modulators Grant 7,541,383 - Fu , et al. June 2, 2 | 2009-06-02 |
Substituted biphenyl GPR40 modulators App 20090137561 - Brown; Sean P. ;   et al. | 2009-05-28 |
Compounds And Methods Useful For Treating Asthma And Allergic Inflammation App 20080312270 - Brown; Matthew ;   et al. | 2008-12-18 |
Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders Grant 7,465,804 - Houze , et al. December 16, 2 | 2008-12-16 |
Benzo-fused compounds for use in treating metabolic disorders App 20080119511 - Brown; Sean P. ;   et al. | 2008-05-22 |
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use Grant 7,375,102 - Fu , et al. May 20, 2 | 2008-05-20 |
Asthma and allergic inflammation modulators App 20080085891 - Fu; Zice ;   et al. | 2008-04-10 |
Asthma and allergic inflammation modulators Grant 7,321,001 - Fu , et al. January 22, 2 | 2008-01-22 |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders App 20070244155 - Sharma; Rajiv ;   et al. | 2007-10-18 |
Imidazolo-related compounds, compositions and methods for their use Grant 7,271,271 - Fu , et al. September 18, 2 | 2007-09-18 |
Modulation of CCR4 function Grant 7,262,204 - Collins , et al. August 28, 2 | 2007-08-28 |
CXCR3 antagonists App 20070149557 - Collins; Tassie L. ;   et al. | 2007-06-28 |
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders App 20070142384 - Akerman; Michelle ;   et al. | 2007-06-21 |
Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders App 20070066647 - Akerman; Michelle ;   et al. | 2007-03-22 |
Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders App 20070015773 - Bergeron; Philippe ;   et al. | 2007-01-18 |
CCR4 antagonists Grant 7,144,903 - Collins , et al. December 5, 2 | 2006-12-05 |
Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders App 20060270724 - Houze; Jonathan ;   et al. | 2006-11-30 |
Pentafluorobenzenesulfonamides and analogs Grant 7,138,418 - Flygare , et al. November 21, 2 | 2006-11-21 |
CXCR3 antagonists Grant 7,067,662 - Medina , et al. June 27, 2 | 2006-06-27 |
CXCR3 antagonists App 20060116388 - Medina; Julio C. ;   et al. | 2006-06-01 |
Substituted Quinazolin-4(3H)-one compounds, compositions, and methods for their use Grant 7,053,215 - Medina , et al. May 30, 2 | 2006-05-30 |
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases App 20060069099 - Fu; Zice ;   et al. | 2006-03-30 |
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use App 20060069106 - Fu; Zice ;   et al. | 2006-03-30 |
Imidazolo-related compounds, compositions and methods for their use App 20060069127 - Fu; Zice ;   et al. | 2006-03-30 |
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders App 20060004012 - Akerman; Michelle ;   et al. | 2006-01-05 |
Substituted pyrido[2,3-d]pyrimidines and methods for their use Grant 6,964,967 - Huang , et al. November 15, 2 | 2005-11-15 |
LXR modulators Grant 6,906,069 - Li , et al. June 14, 2 | 2005-06-14 |
CXCR3 antagonists App 20050075333 - Medina, Julio C. ;   et al. | 2005-04-07 |
Asthma and allergic inflammation modulators App 20050038070 - Inman, Wayne D. ;   et al. | 2005-02-17 |
CXCR3 antagonists App 20040242498 - Collins, Tassie L. ;   et al. | 2004-12-02 |
Asthma and allergic inflammation modulators App 20040220237 - Fu, Zice ;   et al. | 2004-11-04 |
CXCR3 antagonists Grant 6,794,379 - Medina , et al. September 21, 2 | 2004-09-21 |
Modulation of CCR4 function App 20040039035 - Collins, Tassie ;   et al. | 2004-02-26 |
Hydrazones and analogs as cholesterol lowering agents Grant 6,605,615 - Medina , et al. August 12, 2 | 2003-08-12 |
Benzenesulfonamides and benzamides as therapeutic agents Grant 6,583,161 - Medina June 24, 2 | 2003-06-24 |
CXCR3 antagonists App 20030069234 - Medina, Julio C. ;   et al. | 2003-04-10 |
CXCR3 antagonists App 20030055054 - Medina, Julio C. ;   et al. | 2003-03-20 |
Ccr4 antagonists App 20030018022 - Collins, Tassie ;   et al. | 2003-01-23 |
Modulation of CCR4 function App 20020173524 - Collins, Tassie ;   et al. | 2002-11-21 |
CXCR3 antagonists App 20020169159 - Medina, Julio C. ;   et al. | 2002-11-14 |
Hydrazones and analogs as cholesterol lowering agents App 20010056096 - Medina, Julio C. ;   et al. | 2001-12-27 |
LXR modulators Grant 6,316,503 - Li , et al. November 13, 2 | 2001-11-13 |
HIV integrase inhibitors Grant 6,306,891 - Selnick , et al. October 23, 2 | 2001-10-23 |
Benzenesulfonamides and benzamides as therapeutic agents Grant 6,191,170 - Medina February 20, 2 | 2001-02-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.